Sashi Kandel

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity”.

Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity

Advanced Therapeutics(2021)10.1002/adtp.202100087

N/A

0.470DataRank · unranked

22 citations

Sashi Kandel, Umar‐Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu +8 more

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy

Cancer Letters(2021)10.1016/j.canlet.2021.04.011

N/A

0DataRank · unranked

165 citations

Pratik Adhikary, Guangfu Li, Kun Cheng, Sashi Kandel

Recent advances in the development of therapeutic peptides

Trends in Pharmacological Sciences(2023)10.1016/j.tips.2023.04.003

N/A

0DataRank · unranked

134 citations

Sashi Kandel, Umar‐Farouk Mamani, Kun Cheng, John Fetse

Discovery of Anti‐CD47 Peptides as Innate Immune Checkpoint Inhibitors

Advanced Therapeutics(2023)10.1002/adtp.202300114

N/A

0DataRank · unranked

1 citations

John Fetse, Sashi Kandel, Chien‐Yu Lin, Pratik Adhikary, Umar‐Farouk Mamani +5 more

Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy

Pharmaceutical Research(2024)10.1007/s11095-024-03803-1

N/A

0DataRank · unranked

2 citations

Mohammed Nurudeen Ibrahim, Yanli Liu, John Fetse, Chien‐Yu Lin, Sashi Kandel +6 more